Benicar (olmesartan), a new angiotensin receptor blocker for hypertension
June 2002
Reps will soon be promoting Benicar (olmesartan), a new angiotensin receptor blocker for hypertension.
It will be the seventh one on the market...after Cozaar (losartan), Diovan (valsartan), Avapro (irbesartan), Atacand (candesartan), Micardis (telmisartan), and Teveten (eprosartan).
Benicar has a long half-life...but don't get too excited. It's pretty much a "me-too."
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote